Kinaset Therapeutics
Kinaset Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Medfield, Massachusetts, founded in 2020 by Robert Clarke (CEO), Roger Heerman (COO) and Frazer Morgan (CDO) to develop novel inhaled therapeutics for severe respiratory disease. Its lead candidate, frevecitinib (KN-002), is a dry-powder inhaled pan-JAK inhibitor — potent and balanced across JAK1, JAK2, JAK3 and TYK2 — designed as a non-invasive anti-inflammatory add-on to standard of care for all severe asthma patients regardless of the underlying cause of inflammation, and explored in COPD. The company completed a Phase 1/1b program (NCT05006521), received FDA IND clearance, and in July 2026 dosed the first patient in the Phase 2b PANAIRAMA trial (NCT07532265) after closing a $103M oversubscribed Series B in January 2026 led by RA Capital Management and Forge Life Science Partners, with EQT Life Sciences, Vivo Capital, Schroders Capital, Willett Advisors, Pictet Alternative Advisors, Sixty Degree Capital, Atlas Venture, 5AM Ventures and Gimv participating on roughly $143M raised to date. Kinaset is a drug developer, not a software company: its product is a clinical pipeline, and it publishes no developer program, no public API, no SDKs, no webhooks and no machine-readable API contract. Its entire public surface is a 34-page Squarespace marketing and investor-news site whose robots.txt disallows every platform JSON view and blocks the major AI crawlers by user agent.
Index entry only — little beyond a description and a link, and nothing machine-readable enough for an agent to act on without a human reading the site first.
API Evangelist profiles Kinaset Therapeutics the way a machine reads it — 1 machine-readable artifact, pulled from the provider's own public surface and indexed so a developer, an analyst, or an AI agent can evaluate it against every other provider on the network.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — Kinaset Therapeutics scores 4.1/100 (minimal), with a separate agent-readiness read of 0/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Why this profile is thin
Kinaset Therapeutics is a clinical-stage inhaled-respiratory drug developer whose product is the frevecitinib (KN-002) pipeline, not software; its whole public surface is a 34-URL Squarespace marketing and investor-news site with no developer, API or docs route, no api/developer/docs subdomain (NXDOMAIN on all three), no GitHub organization and no first-party package on any registry, and its robots.txt additionally disallows every Squarespace JSON view and blocks the major AI crawlers by user agent.
This is an honest zero, not a gap in our research. Kinaset Therapeutics does not appear to expose an API, so there is nothing here for us to index and nothing for them to fix.
What we probed
https://www.kinasettherapeutics.com/openapi.json→ HTTP 404https://www.kinasettherapeutics.com/swagger.json→ HTTP 404https://www.kinasettherapeutics.com/api-docs→ HTTP 404https://www.kinasettherapeutics.com/graphql→ HTTP 404https://www.kinasettherapeutics.com/_api/mcp→ HTTP 404https://www.kinasettherapeutics.com/.well-known/agent-card.json→ HTTP 404https://www.kinasettherapeutics.com/.well-known/agent.json→ HTTP 404https://www.kinasettherapeutics.com/.well-known/security.txt→ HTTP 404https://www.kinasettherapeutics.com/llms.txt→ HTTP 404https://www.kinasettherapeutics.com/sitemap.xml→ HTTP 200
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.
Kin Score
How this is scored →scored 2026-08-24 · rubric v0.12.1
Put this on your own site. The badge is drawn live from Kinaset Therapeutics's current Kin Score — paste it once and it updates itself every time the score is recomputed. It follows your visitor's light or dark setting, and it links back here so anyone who sees it can read the full breakdown.
<!-- Kin Score · API Evangelist -->
<a href="https://providers.apievangelist.com/providers/kinaset-therapeutics/"
title="Kinaset Therapeutics on API Evangelist — API profile and Kin Score">
<img src="https://apis.io/badge/kinaset-therapeutics.svg"
alt="Kinaset Therapeutics Kin Score — API readiness rating by API Evangelist" width="150" height="150" loading="lazy">
</a>[](https://providers.apievangelist.com/providers/kinaset-therapeutics/)<!-- Kin Score · API Evangelist -->
<a href="https://providers.apievangelist.com/providers/kinaset-therapeutics/"
title="Kinaset Therapeutics on API Evangelist — API profile and Kin Score">
<img src="https://apis.io/badge/kinaset-therapeutics/card.svg"
alt="Kinaset Therapeutics Kin Score — API readiness rating by API Evangelist" width="340" height="120" loading="lazy">
</a>More shapes, themes and sizes → · Score as JSON · How badges work
How we profile Kinaset Therapeutics
Each block below is one kind of artifact we hold for Kinaset Therapeutics. For each we say what it is and why it earns a place in the profile, then list every one we've indexed — capped at two rows, scroll within the panel for the rest.
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals — the evidence that a provider takes security seriously enough to document it. We profile it because you can't govern what you can't see.
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Every other property we hold for Kinaset Therapeutics — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Access & Security 1
Authentication, authorization, and security posture
Company 4
The organization behind the API
Other 1
Properties that don't map to a standard resource type
← All providers · Data indexed from github.com/api-evangelist/kinaset-therapeutics · machine-readable index on apis.io
This is an independent, third-party profile of Kinaset Therapeutics, published by API Evangelist. We do not operate, host, resell, or support these APIs, and we are not affiliated with or endorsed by the company unless stated above. Everything here is built from publicly available information — the company's own site, developer portal, documentation, public repositories, and the specifications it publishes for public use. Nothing is obtained by breaching a system, defeating an access control, or using credentials.
The Kin Score and Agent Readiness rating are independently calculated assessments of a company's public API artifacts, scored against a published rubric. They are not certifications, endorsements, security assessments, or audits.
Corrections, re-scores, and removal are free — no partnership or purchase required, and you do not need to justify the request. A removed company is recorded as unrated, never scored zero for having asked. Acknowledgement within one business day; removal within two.
info@apievangelist.com
·
Read the full data-sourcing policy →
On a security or compliance team? Put security in the subject line and
you will get a person, not a form — we will tell you exactly which public URLs this profile was built from.